Congenica to Provide Tertiary Analysis for Whole Genome Sequencing for Hong Kong Genome Project
March 16, 2022
Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces that it has been selected to provide tertiary analysis for whole genome sequencing services for the Hong Kong Genome Project (HKGP), the first large-scale genome sequencing initiative in Hong Kong. The HKGP, being [...]
Parallel Photoreactor Offers Easy Interchangeable Wavelength Excitation
March 16, 2022
Asynt has introduced a new modular version of its popular LightSyn Illumin8 photoreactor. This innovative system provides researchers with the flexibility to change quickly and safely between a selection of high-power light emitting diodes (LEDs) operating at wavelengths including UV (365 nm) and blue (450 nm). The LightSyn Illumin8 allows chemists to run up to 8 [...]
Corbeau Innovation named as New UK Distributor for ELODIZ Ltd
March 16, 2022
We are delighted to announce the appointment of Corbeau Innovation as authorised distributor of ELODIZ Raman products in the UK with exclusive distribution rights from 16 March 2022. Based in Cardiff, Corbeau Innovation specialises in innovative spectroscopy products. They partner companies with disruptive technologies, helping them to rapidly develop and sell their products, targeting markets [...]
March 16, 2022
Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific’s portfolio of end-to-end cell therapy solutions CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages [...]
March 16, 2022
Illumina Accelerator portfolio grows to 68 startups 93% of graduate companies successfully secured additional capital SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK. The global company creation engine is focused on partnering with entrepreneurs to [...]
Bruker Appoints Philip Ma to its Board of Directors
March 16, 2022
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. Dr. Ma is Chief Executive Officer, founder, and a director of PrognomiQ, a privately held healthcare company that is developing next-generation, transformative multiomics products to enable [...]
March 16, 2022
Gibco CTS Xenon Electroporation System complements Thermo Fisher Scientific’s portfolio of end-to-end cell therapy solutions CARLSBAD, Calif. – Thermo Fisher Scientific, the world leader in serving science, has introduced a new large-volume electroporation system that allows cell therapy developers to more easily move from clinical development to commercial manufacturing. The Gibco CTS Xenon Electroporation System leverages [...]
Illumina and Trivitron Partner to Accelerate Disease Detection and Diagnosis for Patients in India
March 15, 2022
Partnership will expand use of next-generation sequencing (NGS) to help diagnose patients quickly and more accurately. NEW DELHI - Illumina Singapore, subsidiary of Illumina Inc (NASDAQ: ILMN) and Trivitron Healthcare, one of India's largest medical technology companies, have entered into a strategic partnership to develop and expand the use of next-generation sequencing (NGS)-based in-vitro diagnostic tests (IVD) [...]
March 15, 2022
Launch marks product’s first use in a commercial therapeutic SUNNYVALE, California – JSR Life Sciences, LLC today announced that its lead product, Amsphere™ A3 has been incorporated for the first time into the commercial manufacturing of an FDA-approved treatment. Amsphere™ A3 is a next generation Protein-A chromatography resin that enables advanced protein separation in downstream processing [...]
CS Genetics Appoints Jay Harger, PhD, as Senior Vice President of Operations
March 15, 2022
Experienced Product and Operations Leader to Accelerate Delivery of Ambitious Roadmap in Single Cell Genomics SAN DIEGO, Calif. and CAMBRIDGE, UK -- CS Genetics, a privately held genomics-technology company, today announced the appointment of Jay Harger, PhD, as Senior Vice President of Operations. Jay will lead a variety of critical company operations including facilities, manufacturing [...]

